Literature DB >> 16771684

Cross-talk between constitutive and inducible NO synthase: an update.

Tiziana Persichini1, Orazio Cantoni, Hisanori Suzuki, Marco Colasanti.   

Abstract

Inducible nitric oxide synthase (iNOS) is expressed upon exposure of some cell types to bacterial lipopolysaccharides (LPS) and/or a variety of proinflammatory cytokines. The authors present an overview of some of the recent findings further supporting the notion that this response takes place after an early decline in constitutive nitric oxide (NO) levels (i.e., NO released by constitutive NOS, cNOS). This response is indeed critical for allowing activation of the transcription factor NF-kappaB. Thus, generation of NO by cNOS represents a limiting factor for iNOS expression. Some of the physiological and pathological implications of the cross-talk between these two NOS isoforms are discussed. In addition, the results of recent studies are summarized, suggesting possible mechanisms whereby LPS and/or proinflammatory cytokines may cause inhibition of cNOS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16771684     DOI: 10.1089/ars.2006.8.949

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  17 in total

1.  Macrophage immunomodulatory activity of polysaccharides isolated from Opuntia polyacantha.

Authors:  Igor A Schepetkin; Gang Xie; Liliya N Kirpotina; Robyn A Klein; Mark A Jutila; Mark T Quinn
Journal:  Int Immunopharmacol       Date:  2008-07-01       Impact factor: 4.932

2.  Asymmetric dimethylarginine potentiates lung inflammation in a mouse model of allergic asthma.

Authors:  Elizabeth Klein; Jason Weigel; Mary C Buford; Andrij Holian; Sandra M Wells
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-01       Impact factor: 5.464

3.  Immunomodulatory activity of acidic polysaccharides isolated from Tanacetum vulgare L.

Authors:  Gang Xie; Igor A Schepetkin; Mark T Quinn
Journal:  Int Immunopharmacol       Date:  2007-09-05       Impact factor: 4.932

4.  Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease.

Authors:  Dana B Hancock; Eden R Martin; Jeffery M Vance; William K Scott
Journal:  Neurogenetics       Date:  2008-07-29       Impact factor: 2.660

Review 5.  Adenosine: an immune modulator of inflammatory bowel diseases.

Authors:  Jeff Huaqing Ye; Vazhaikkurichi M Rajendran
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

6.  Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology.

Authors:  Alessandro Capuano; Alice De Corato; Lucia Lisi; Giuseppe Tringali; Pierluigi Navarra; Cinzia Dello Russo
Journal:  Mol Pain       Date:  2009-08-06       Impact factor: 3.395

7.  Lipopolysaccharide regulates biosynthesis of cystathionine γ-lyase and hydrogen sulfide through Toll-like receptor-4/p38 and Toll-like receptor-4/NF-κB pathways in macrophages.

Authors:  Yijie Zheng; Naixiang Luo; Dongzhen Mu; Pei Jiang; Ronghua Liu; Haozhe Sun; Shudao Xiong; Xiaoming Liu; Luman Wang; Yiwei Chu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-07-23       Impact factor: 2.416

8.  Nitric oxide synthase isoforms expression in fibroblasts isolated from human normal peritoneum and adhesion tissues.

Authors:  Zhong L Jiang; Xuping Zhu; Michael P Diamond; Husam M Abu-Soud; Ghassan M Saed
Journal:  Fertil Steril       Date:  2008-04-28       Impact factor: 7.329

9.  Bovine herpesvirus 5 induces an overproduction of nitric oxide in the brain of rabbits that correlates with virus dissemination and precedes the development of neurological signs.

Authors:  R Dezengrini; M Weiss; F D Torres; M S Oliveira; F Furian; C F Mello; R Weiblen; E F Flores
Journal:  J Neurovirol       Date:  2009-04       Impact factor: 2.643

10.  iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells.

Authors:  Sara De Boo; Joanna Kopecka; Davide Brusa; Elena Gazzano; Lina Matera; Dario Ghigo; Amalia Bosia; Chiara Riganti
Journal:  Mol Cancer       Date:  2009-11-19       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.